DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

Sun Pharmaceutical Industries Limited — Outcome of Board Meeting

NSE 57 min ago·12 Oct 2026, 2:27 pm

SUN Pharmaceutical IND L

Sun Pharmaceutical Industries Limited has announced the outcome of its board meeting held on 12 October 2026. The company has informed the stock exchanges that the board has approved and adopted the financial statements for the quarter ended September 30, 2026. This standard corporate disclosure is a routine update required for all listed entities to ensure transparency regarding their financial health.

This development is primarily a compliance update for investors. By adopting the unaudited financial results, the company confirms that its internal financial controls are functioning as expected. For the retail investor, this news serves as a confirmation point rather than a market-moving catalyst, as the results have already been disclosed to the exchanges.

Moving forward, the market will likely focus on the detailed financial performance disclosed in the press release. Investors should watch for commentary on revenue growth, operating margins, and the company's outlook for the upcoming quarters. These details will provide a clearer picture of the company's operational momentum.